Mylan Woes Get Worse With Top Executive Engulfed in Vast Probe – Bloomberg

Mylan Woes Get Worse With Top Executive Engulfed in Vast Probe – Bloomberg

Bloomberg

Mylan Woes Get Worse With Top Executive Engulfed in Vast Probe
Bloomberg
Two years ago, Mylan was a swaggering drugmaker on the way up, buying up rivals as it grew and diversified. Then it faced political scrutiny over price hikes for its EpiPen allergy shot and increasing pressure on prices for the generic drugs that are
A price-fixing noose tightens around Mylan, the company that profiteered from the EpipenLos Angeles Times


Mylan President, Emcure Exec Targeted by States in Generic Drug LawsuitTheStreet.com
States target Mylan's president in generic drug pricing probeChicago Tribune
Business Insider –CNBC –Forbes –Hartford Courant
all 53 news articles »

0
Like
Save

Comments

Comments are disabled for this post.